PubRank

David J Chambers

Author PubWeight™ 17.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role? Eur J Cardiothorac Surg 2005 2.03
2 Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg 2002 1.47
3 Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution. Interact Cardiovasc Thorac Surg 2008 1.44
4 Does intermittent cross-clamp fibrillation provide equivalent myocardial protection compared to cardioplegia in patients undergoing bypass graft revascularisation? Interact Cardiovasc Thorac Surg 2009 1.41
5 Ischaemic postconditioning: does cardioplegia influence protection? Eur J Cardiothorac Surg 2012 1.39
6 Antidepressants and falls in the elderly. Drugs Aging 2009 1.19
7 Changes in P-selectin expression on cardiac microvessels in blood-perfused rat hearts subjected to ischemia-reperfusion. Ann Thorac Surg 2005 0.93
8 Targeting for cardioplegia: arresting agents and their safety. Curr Opin Pharmacol 2009 0.89
9 Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res 2010 0.83
10 Oxidative stress injury during cardiac surgery: how important is it? Cardiovasc Res 2007 0.83
11 Stereospecific synthesis of 1,2-cis glycosides by vinyl-mediated IAD. Org Lett 2004 0.83
12 Plasma from patients with sepsis up-regulates the expression of CD49d and CD64 on blood neutrophils. Am J Respir Cell Mol Biol 2008 0.83
13 Long-term hypothermic lung preservation: does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection? Interact Cardiovasc Thorac Surg 2004 0.81
14 Future perspective of cardioplegic protection in cardiac surgery. J Nippon Med Sch 2013 0.78
15 Myocardial infarction comes into the cold! Ann Thorac Surg 2009 0.77
16 ICVTS on-line discussion A. The safety of using millimolar doses of lidocaine as cardioplegia. Interact Cardiovasc Thorac Surg 2007 0.75
17 Is blood versus crystalloid cardioplegia relevant? Significantly improved protection may require new cardioplegic concepts! Interact Cardiovasc Thorac Surg 2008 0.75
18 Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution. Eur J Cardiothorac Surg 2012 0.75
19 Stereoselective synthesis of C-glycosides from carboxylic acids: the tandem Tebbe-Claisen approach. Org Biomol Chem 2003 0.75
20 Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide. Ann Thorac Surg 2004 0.75
21 Stereoselective 1,2-cis glycosylation of 2-O-allyl protected thioglycosides. Chemistry 2002 0.75